High Quality Peptides Lyophilized Powder Tesamorelin 2mg CAS 218949-48-5 Anti Aging Steroids

Quick Detail:

Product Name: Tesamorelin

Other Name: usan; Egrifta

CAS: 218949-48-5

MF: C211H366N72O67S1

MW: 5135.89

Appearance: white powder

Purity (HPLC): 99.3%

Molecular Weight:5135.89

Appearance:white powder

Packing :According to every customer's requirement.

Catrgory :Polypeptides Hormone

Tesamorelin Description:

Tesamorelin is made with growth hormone-releasing factor (GRF).Tesamorelin is used to reduce excess fat around the stomach that is caused by taking certain HIV medications. This condition is also called lipodystrophy (LYE-poe-DIS-troe-fee).Tesamorelin is not a weight-loss medication and should not be used to treat obesity.

Tesamorelin is the only FDA drug approved for the intended reduction of abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection. It stimulates the body's release of growth hormone, which is reduced in HIV lipodystrophy.

Those who are infected with the HIV virus must sometimes deal with a health issue which is known as
lipodystrophy. This is a syndrome which is triggered by different causes. Certain people with this health issue (one in four of HIV patients), experience fat loss – however, others experience weight gain in key areas, including the throat, the chest (or breasts) and the tummy. In addition to this weight gain, increased blood fat levels and differences in insulin levels may be present.

Tesamorelin is a synthetic peptide consisting of all 44 amino acids of hGRF with the addition of a trans-3-Hexenoic acid group.
Tesamorelin ( also known as Egrifta) is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy.
p; tendon fibroblasts in a dose-dependent manner as revealed by transwell filter migration assay. BPC 157 also dose dependently accelerated the spreading of tendon fibroblasts on culture dishes. The F-actin formation as detected by FITC-phalloidin staining was induced in BPC 157-treated fibroblasts. The protein expression and activation of FAK and paxillin were determined by Western blot analysis, and the phosphorylation levels of both FAK and paxillin were dose dependently increased by BPC 157 while the total amounts of protein was unaltered. In conclusion, BPC 157 promotes the ex vivo outgrowth of tendon fibroblasts from tendon explants, cell survival under stress, and the in vitro migration of tendon fibroblasts, which is likely mediated by the activation of the FAK-paxillin pathway.
nbsp; was responsible for pituitary stimulation. In 1999 researchers Goa and Prakash checked sermorelin GH as provocative tasting method for deficiency of endogenous G-hormone.
The most known features of this research compound are increasing lean muscular tissue mass, reducing fat, increasing bone tissue density and even enhancing functioning of immune system. It complies with certain amino-segment of natural long-chained GHrh. Sermorelin helps to convert exceeded volume of GH by liver into IGF-1.

Function:

Tesamorelin is the only FDA drug approved for the intended reduction of abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection. It stimulates the body's release of growth hormone, which is reduced in HIV lipodystrophy.

Those who are infected with the HIV virus must sometimes deal with a health issue which is known as
lipodystrophy. This is a syndrome which is triggered by different causes. Certain people with this health issue (one in four of HIV patients), experience fat loss – however, others experience weight gain in key areas, including the throat, the chest (or breasts) and the tummy. In addition to this weight gain, increased blood fat levels and differences in insulin levels may be present.